- Home
- TNXP vs MVIS Comparison
TNXP vs MVIS Comparison
Compare TNXP & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- MVIS
- Stock Information
- Founded
- TNXP 2007
- MVIS 1993
- Country
- TNXP United States
- MVIS United States
- Employees
- TNXP N/A
- MVIS N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- MVIS Industrial Machinery/Components
- Sector
- TNXP Health Care
- MVIS Technology
- Exchange
- TNXP Nasdaq
- MVIS Nasdaq
- Market Cap
- TNXP 335.6M
- MVIS 274.2M
- IPO Year
- TNXP N/A
- MVIS 1996
- Fundamental
- Price
- TNXP $28.35
- MVIS $1.24
- Analyst Decision
- TNXP Buy
- MVIS Strong Buy
- Analyst Count
- TNXP 1
- MVIS 3
- Target Price
- TNXP $70.00
- MVIS $2.50
- AVG Volume (30 Days)
- TNXP 1.2M
- MVIS 3.3M
- Earning Date
- TNXP 11-11-2025
- MVIS 11-06-2025
- Dividend Yield
- TNXP N/A
- MVIS N/A
- EPS Growth
- TNXP N/A
- MVIS N/A
- EPS
- TNXP N/A
- MVIS N/A
- Revenue
- TNXP $9,831,000.00
- MVIS $2,584,000.00
- Revenue This Year
- TNXP $14.79
- MVIS $47.70
- Revenue Next Year
- TNXP $933.49
- MVIS $478.91
- P/E Ratio
- TNXP N/A
- MVIS N/A
- Revenue Growth
- TNXP N/A
- MVIS N/A
- 52 Week Low
- TNXP $6.76
- MVIS $0.80
- 52 Week High
- TNXP $130.00
- MVIS $1.95
- Technical
- Relative Strength Index (RSI)
- TNXP 41.38
- MVIS 65.02
- Support Level
- TNXP $26.89
- MVIS $1.12
- Resistance Level
- TNXP $29.19
- MVIS $1.17
- Average True Range (ATR)
- TNXP 2.18
- MVIS 0.05
- MACD
- TNXP 0.39
- MVIS 0.01
- Stochastic Oscillator
- TNXP 56.46
- MVIS 85.00
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.